An in vivo study using a murine model revealed that treatment with exosomes loaded with recombinant IL-10 during pregnancy decreased inflammation caused by infections, reducing the risk of placental damage, including the effects of this phenomenon such as pre-term birth [178], a phenomenon caused by infection with some viruses, as addressed in the previous section. This evidence concerns the gene IL10 and infection.